{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/regenxbio-completes-dosing-in-confirmatory-study-of-rgx-202-marking-completion-of-registrational-development-program-and-supporting-planned-bla-submission-in-q3-2026-302808616.html", "message": "News view counter 813909 successfully enlarged"}